go to home page team portfolio news contact
selected releases
selected releases

Quick Notes

Nest Collective
#1 on Fast 100,
a list of the fastest
growing Bay Area
companies by
San Francisco
Business Times

 

Akermin
Receives $2.6 million
from U.S. Department
of Energy for two-year
carbon capture project

 
Prolog
Ilya Nykin discussed
exploring corporate
venture capital at
New York Venture
Summit’s “More
Than Money” panel

 

Stereotaxis
Live cardiac ablation
procedure featured on
NBC’s TODAY Show

 

Veran
Receives approval from
the FDA to market its
endobronchial navigation
system

  Prolog and Our Portfolio Companies in the News
       
 
post masthead
 
With the sale of Divergence, we got a
success story worth talking about
Complete Article >

 
webmd masthead
 
If you eat tortilla chips, here’s a new brand you might really enjoy: Corazonas
Complete Article >
       
 
youitube
 
Nest co-founder Sheryl O’Loughlin, finalist
of Entrepreneur of the Year Award, on CBS
Watch Interview>
 
nytimes masthead
 
EndoStim is the epitome of the new kind of startups we need to propel our economy
Complete Article >
         
 
tonic
 
Thanks to Plum Organics, a Nest Collective brand, more babies are eating healthy foods each day
Complete Article >
 
prevention
  Attune Foods is one of
three favorite products
within “The Newest
Belly Flattener”
cover story
Article Excerpts >
       
 

post masthead
 
Prolog views nutrition and wellness as a
bright spot in the venture capital landscape:
“People still read food labels”
Article Excerpts >
     

american venture
  Prolog offers advice
for entrepreneurs
seeking capital
Complete Article >
     

  Prolog's directors
combine their
multiple skills to
help their St. Louis
life science ventures
flourish
Complete Article >
 
 

 
Research suggests that APT Therapeutics' experimental drug helps block blood platelets from aiding cancer cells
Complete Article >

     


  Prolog discusses the
merits of investing
in the health and
wellness space
Article Excerpts >
     

  Prolog interviewed in
“The Enabler,”
an article on Prolog’s investments in St. Louis’ life science ventures
Complete Article >
     
 

 

T O P   S E L E C T E D   R E L E A S E S   H O M E